Abstract
The objective of this study is to utilize the pH sensitivity of modified mesoporous silica nanoparticles (MSN) for oral delivery of insulin. Activated silica nanoparticle was modified first with different densities of 3- Chloropropyltrimethoxysilane (3-CTMS) to load the Chlor group which will bond with the organic functional group contained in 4-hydroxybenzoic acid (4-HBA). The nanoparticles were characterized by FTIR and SEM. Equilibrium swelling studies were carried out in enzyme-free simulated gastric and intestinal fluids (SGF and SIF, respectively). Insulin was entrapped in these nanoparticles and the in vitro release profiles were established separately in both (SGF, pH 1) and (SIF, pH 7.4). The amount of loading of insulin was increased with increasing -COO- densities resulting from the increasing number of 4-HBA groups. In these cases, the biological activity of insulin was retained. These results were used to design and improve protein release behavior from these carriers.
Keywords: Silica nanoparticles, 4-hydroxybenzoic acid, pH-sensitive, insulin, oral drug delivery, Activated silica, 3-Chloropropyltrimethoxysilane, in vitro, swelling, release behavior, FTIR, SEM
Current Drug Delivery
Title: Synthesis and Characterization of pH-Sensitive Silica Nanoparticles for Oral-Insulin Delivery
Volume: 8 Issue: 6
Author(s): Mehrdad Mahkam
Affiliation:
Keywords: Silica nanoparticles, 4-hydroxybenzoic acid, pH-sensitive, insulin, oral drug delivery, Activated silica, 3-Chloropropyltrimethoxysilane, in vitro, swelling, release behavior, FTIR, SEM
Abstract: The objective of this study is to utilize the pH sensitivity of modified mesoporous silica nanoparticles (MSN) for oral delivery of insulin. Activated silica nanoparticle was modified first with different densities of 3- Chloropropyltrimethoxysilane (3-CTMS) to load the Chlor group which will bond with the organic functional group contained in 4-hydroxybenzoic acid (4-HBA). The nanoparticles were characterized by FTIR and SEM. Equilibrium swelling studies were carried out in enzyme-free simulated gastric and intestinal fluids (SGF and SIF, respectively). Insulin was entrapped in these nanoparticles and the in vitro release profiles were established separately in both (SGF, pH 1) and (SIF, pH 7.4). The amount of loading of insulin was increased with increasing -COO- densities resulting from the increasing number of 4-HBA groups. In these cases, the biological activity of insulin was retained. These results were used to design and improve protein release behavior from these carriers.
Export Options
About this article
Cite this article as:
Mahkam Mehrdad, Synthesis and Characterization of pH-Sensitive Silica Nanoparticles for Oral-Insulin Delivery, Current Drug Delivery 2011; 8 (6) . https://dx.doi.org/10.2174/156720111797635522
DOI https://dx.doi.org/10.2174/156720111797635522 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Meet Our Associate Editor
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) G Protein-Coupled Receptor Kinase 2 - a Feedback Regulator of Gq Pathway Signalling
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Circulating Insulin-like Growth Factor-1 Levels in Patients with Rheumatoid Arthritis: A Meta-analysis
Current Pharmaceutical Design Identification of New Susceptibility Genes for Type 1 Diabetes: An Update
Current Immunology Reviews (Discontinued) Ursolic Acid and Oleanolic Acid: Pentacyclic Terpenoids with Promising Anti-Inflammatory Activities
Recent Patents on Inflammation & Allergy Drug Discovery From Brain Ischemia-Reperfusion Injury to Possible Sporadic Alzheimers Disease
Current Neurovascular Research Natural Alkaloids and Diabetes Mellitus: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Ghetto Poverty and Pollution in Egypt: A Deadly Threat for Western Countries Caused by New and Infectious Mutants. A Cultural, Social and Microbiological Synopsis
Inflammation & Allergy - Drug Targets (Discontinued) Uveitis in Rheumatic Diseases
Current Rheumatology Reviews Advances in High-Field Magnetic Resonance Spectroscopy in Alzheimer’s Disease
Current Alzheimer Research Targeting Fatty Acid Metabolism in the Treatments of Obesity and Disorders of CNS Cellular Energy Balance
Central Nervous System Agents in Medicinal Chemistry The Arrestin Fold: Variations on a Theme
Current Genomics Systemic Approach to Parenteral Nutrition in the ICU
Current Drug Safety Statins Therapy for Connective Tissue Diseases: New Therapeutic Opportunities
Endocrine, Metabolic & Immune Disorders - Drug Targets Chiral Kinase Inhibitors
Current Topics in Medicinal Chemistry Proteomics Approach for Biomarker Research in Major Depression: Antidepressant Effects
Current Drug Metabolism Identification of New Pancreatic Beta Cell Targets for In Vivo Imaging by a Systems Biology Approach
Current Pharmaceutical Design Editorial [Hot Topic: New Concepts of Angiotensin Receptor Blocker (ARB) in Atherosclerosis: ARB as a Metabolic-Improving Agent (Guest Editor: Minako Yamaoka-Tojo)]
Current Vascular Pharmacology Personalized Medicine and Molecular Diagnostics for Obesity: Metabolic Systems Reconstruction and Gut Microbiome Biomarkers
Current Pharmacogenomics and Personalized Medicine The Role of Novel Biomarkers of Cardiovascular Disease in Chronic Kidney Disease: Focus on Adiponectin and Leptin
Current Cardiology Reviews